Actual Medicinal Product (AMP) Dalacin C 75mg capsules (Pfizer Ltd)

Stability Information

(Some stability information inherited from generic)

Stability: Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes: Moisture sensitive medicine. Store in airtight (sealed) MCA.
Provenance: This recommendation is based on the products Dalacin C 75mg capsules (Pfizer Limited) and Clindamycin 75mg capsules (Brown & Burk UK Ltd).
Generic: Clindamycin
Formulation: Clindamycin 75mg capsules

Clindamycin
- Clindamycin 75mg capsules
  - Dalacin C 75mg capsules (Pfizer Ltd)